LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
BCIQ Data Coverage
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
3rd Biotech CEO & Investor Reception
East-West Biopharma Summit 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Sabin Vaccine Institute
Headquarters:
Washington, DC, United States
Website:
http://www.sabin.org
Year Founded:
1993
Status:
Non-biopharma
Biopharma related deals can be found by searching the organization's name in the
Deals
Module.
BioCentury
|
Jan 14, 2023
Finance
Jan. 13 Quick Takes: Stevens’ Structure Therapeutics files for IPO
Plus: Expanded label for Novo’s Rybelsus and updates from China Resources, LinusBio, MPC Therapeutics, Sabin and more
Read More
BioCentury
|
May 19, 2022
Product Development
May 18 Quick Takes: Enanta tumbles after hours after missing RSV endpoint
Plus: House E&C passes user fee bill and updates from Hengrui, Laekna, Prenetics, Enanta and more
Read More
BioCentury
|
Jul 7, 2021
Management Tracks
In GSK’s Hoos, Scorpion gains oncology pathfinder to match its $270M war chest
Departure follows rebuild of pharma’s cancer pipeline
Read More
BioCentury
|
Jun 2, 2020
Product Development
Daily Chart: modeling benchmarks for COVID-19 vaccines
Read More
BioCentury
|
Aug 6, 2019
Company News
Why GSK picked Sabin to advance its Ebola vaccines
Read More
BioCentury
|
Dec 14, 2015
Company News
Sabin Vaccine Institute, Baylor, Brighton Biotech, Texas Children’s Hospital deal
Read More
BioCentury
|
Feb 6, 2012
Clinical News
Human hookworm vaccine: Phase I started
Read More
BioCentury
|
Jan 12, 2012
Politics & Policy
Initiative launches campaign to eliminate 7 diseases
Read More
BioCentury
|
Mar 28, 2011
Strategy
Gates after Yamada
Challenges for Yamada's global health successor at Gates Foundation
Read More
BioCentury
|
Sep 18, 2006
Company News
Bill & Melinda Gates Foundation, Infectious Disease Research Institute, Public Library of Science, Sabin Vaccine Institute, University of North Carolina infecti
Read More
Items per page:
10
1 - 10 of 12